Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (SHA: 688796, HKG: 2315) announced a strategic partnership with Sihuan...
Guizhou Sanli Pharmaceutical Co., Ltd. (SHA: 603439) announced the transfer of marketing authorizations and comprehensive...
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA: 600196, HKG: 2196) announced it has received approval...
China’s National Medical Products Administration (NMPA) has granted approval for 99mTc-3PRGD2, a Category 1 radionuclide...
Sichuan Biokin Pharmaceutical Co., Ltd. (SHA: 688506) announced it has received approval from China’s National...
Zai Lab (NASDAQ: ZLAB, HKG: 9688) and Amgen Inc. (NASDAQ: AMGN) announced a strategic collaboration...
China’s Center for Drug Evaluation (CDE) has published the 105th batch of reference preparations for...
Eli Lilly and Company (NYSE: LLY) announced it has received marketing approval from the US...
Eisai Co., Ltd. (TYO: 4523) announced the commercial launch of a 14-tablet specification of its...
China’s National Medical Products Administration (NMPA) today released its comprehensive “Implementation Opinions on ‘AI +...
Shanghai BDgene Technology Co., Ltd. announced the successful closing of a financing round securing hundreds...
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA: 600196, HKG: 2196) announced it has received clearance...
Rui Therapeutics, a China-based cell therapy developer, announced it has received approval from the National...
Changchun High & New Technology Industries (Group) Inc. (SHE: 000661) announced it has received approval...
Sirius Therapeutics, a clinical-stage biotechnology company founded in 2021, announced it has submitted its listing...
Alphamab Oncology (HKG: 9966) announced that the Phase III KN026-004 clinical study evaluating anbenitamab in...
Sanofi (NASDAQ: SNY) announced that the European Commission (EC) has granted conditional marketing authorization for...
Gilead Sciences Inc. (NASDAQ: GILD) and Galapagos NV (NASDAQ: GLPG) announced a comprehensive collaboration to...
Merck & Co., Inc. (MSD; NYSE: MRK) announced a strategic collaboration with fellow US biotech...
Biogen Inc. (NASDAQ: BIIB) announced that the U.S. Food and Drug Administration (FDA) has approved...